Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine for Diastolic Function in CHD
NCT03887013Phase 4Unknown
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Mar 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimetazidine in diastolic dysfunction, coronary heart disease (CHD), sponsored by National Center for Cardiovascular Disease. Status: unknown.
02
Drugs
trimetazidine
03
Conditions
diastolic dysfunctioncoronary heart disease (CHD)
Beyond the preview
Go deeper on NCT03887013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887013.